Evaluation of Optimal Dose of Local Anesthetics for Patient Controlled Continuous Femoral Nerve Block
2 other identifiers
interventional
60
1 country
1
Brief Summary
To evaluate an analgesic effect without basal administration of local anesthetics for patient-controlled femoral nerve block (with sciatic nerve block) after total knee arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 8, 2010
CompletedFirst Posted
Study publicly available on registry
September 10, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedJuly 22, 2011
August 1, 2010
1.5 years
September 8, 2010
July 20, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
pain scores by use of numerous rating scale (NRS)
4 days after the surgery
Secondary Outcomes (1)
dose of local anesthetics
4 days after the surgery
Study Arms (2)
With basal local anesthetics
ACTIVE COMPARATORWithout basal local anesthetics
EXPERIMENTALInterventions
Administration of 0.2% ropivacaine for femoral nerve block with 3 ml/h of basal dose, 5ml bolus by the patient, 60 minutes of lock out time.
Administration of 0.2% ropivacaine for femoral nerve block without basal dose, with 8 ml bolus by the patient, 60 minutes of lockout time.
Eligibility Criteria
You may qualify if:
- patients older than 20 yrs old scheduled for total knee arthroplasty
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Anesthesiology and Resuscitology, Okayama University Hospital
Okayama, Okayama-ken, 700-8558, Japan
Study Officials
- PRINCIPAL INVESTIGATOR
Hideki Taninishi, MD, PhD
Okayama University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 8, 2010
First Posted
September 10, 2010
Study Start
September 1, 2010
Primary Completion
March 1, 2012
Study Completion
June 1, 2012
Last Updated
July 22, 2011
Record last verified: 2010-08